These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1413442)

  • 21. The efficacy of a generic doxycycline tablet in the treatment of canine monocytic ehrlichiosis.
    Fourie JJ; Horak I; Crafford D; Erasmus HL; Botha OJ
    J S Afr Vet Assoc; 2015 Mar; 86(1):1193. PubMed ID: 26018824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam.
    Eichstadt LR; Moore GE; Childress MO
    Vet Comp Oncol; 2017 Dec; 15(4):1346-1353. PubMed ID: 27714960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine ehrlichiosis in six dogs with persistently increased antibody titers.
    Perille AL; Matus RE
    J Vet Intern Med; 1991; 5(3):195-8. PubMed ID: 1920256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective comparative study of 3 treatment protocols using doxycycline or imidocarb dipropionate in dogs with naturally occurring ehrlichiosis.
    Sainz A; Tesouro MA; Amusategui I; Rodríguez F; Mazzucchelli F; Rodríguez M
    J Vet Intern Med; 2000; 14(2):134-9. PubMed ID: 10772483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical comparison of two injectable oxytetracycline preparations for the treatment of pneumonia in calves.
    Bols PE; de Kruif A
    Vet Q; 1995 Mar; 17(1):6-8. PubMed ID: 7610558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of long-acting oxytetracycline for the prevention of tick-borne fever in calves.
    Cranwell MP
    Vet Rec; 1990 Apr; 126(14):334-6. PubMed ID: 2339491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tick acquisition of Ehrlichia canis from dogs treated with doxycycline hyclate.
    Schaefer JJ; Needham GR; Bremer WG; Rikihisa Y; Ewing SA; Stich RW
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3394-6. PubMed ID: 17606682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
    Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
    Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog.
    Toom ML; Dobak TP; Broens EM; Valtolina C
    Acta Vet Scand; 2016 Jul; 58(1):46. PubMed ID: 27388158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of low-dose cyclophosphamide with piroxicam on tumour neovascularization in a canine oral malignant melanoma-xenografted mouse model.
    Choisunirachon N; Jaroensong T; Yoshida K; Saeki K; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
    Vet Comp Oncol; 2015 Dec; 13(4):424-32. PubMed ID: 23890026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of desmopressin on immune-mediated haemorrhagic disorders due to canine monocytic ehrlichiosis: a preliminary study.
    Giudice E; Giannetto C; Gianesella M
    J Vet Pharmacol Ther; 2010 Dec; 33(6):610-4. PubMed ID: 21108506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effect of intramuscular diclofenac, ketorolac or piroxicam on post-operative pain following laparoscopy.
    O'Hanlon JJ; Beers H; Huss BK; Milligan KR
    Eur J Anaesthesiol; 1996 Jul; 13(4):404-7. PubMed ID: 8842665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of different substance combinations in a multiple-session mesotherapy protocol for the management of osteoarthritis in dogs: a retrospective study.
    Alves JC; Santos A; Lafuente P
    J Am Vet Med Assoc; 2024 Aug; 262(8):1-7. PubMed ID: 38503053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
    Rossi F; Sabattini S; Vascellari M; Marconato L
    Vet Comp Oncol; 2018 Dec; 16(4):497-504. PubMed ID: 29806156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of long acting oxytetracycline in the laboratory rat.
    Curl JL; Curl JS; Harrison JK
    Lab Anim Sci; 1988 Aug; 38(4):430-4. PubMed ID: 3184852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the serum pharmacokinetics of a long acting and a conventional oxytetracycline injection.
    Davey LA; Ferber MT; Kaye B
    Vet Rec; 1985 Oct; 117(17):426-9. PubMed ID: 4071932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
    Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
    J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study of ehrlichiosis in 62 dogs from North Carolina and Virginia.
    Frank JR; Breitschwerdt EB
    J Vet Intern Med; 1999; 13(3):194-201. PubMed ID: 10357108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of parenteral long-acting and topical oxytetracycline, without hoof trimming, for treatment of footrot in goats.
    Laven R
    N Z Vet J; 2012 May; 60(3):213-4. PubMed ID: 22480360
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
    Upton ML; Tangner CH; Payton ME
    J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.